2024 Q3 Form 10-Q Financial Statement
#000121390024069173 Filed on August 14, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 | 2023 Q4 |
---|---|---|---|
Revenue | $2.541M | $3.431M | $1.017M |
YoY Change | 200.71% | 80.96% | -59.87% |
Cost Of Revenue | $798.0K | $1.488M | $663.0K |
YoY Change | 28.92% | 17.72% | -54.68% |
Gross Profit | $1.743M | $1.943M | $354.0K |
YoY Change | 671.24% | 207.44% | -66.95% |
Gross Profit Margin | 68.6% | 56.63% | 34.81% |
Selling, General & Admin | $1.517M | $1.437M | $1.424M |
YoY Change | -8.72% | -14.52% | -39.61% |
% of Gross Profit | 87.03% | 73.96% | 402.26% |
Research & Development | $543.0K | $603.0K | $585.0K |
YoY Change | -21.42% | -9.87% | -18.41% |
% of Gross Profit | 31.15% | 31.03% | 165.25% |
Depreciation & Amortization | $3.000K | $4.000K | $7.000K |
YoY Change | -70.0% | -33.33% | -216.67% |
% of Gross Profit | 0.17% | 0.21% | 1.98% |
Operating Expenses | $2.060M | $1.877M | $2.009M |
YoY Change | -12.45% | -20.13% | -34.67% |
Operating Profit | -$317.0K | $66.00K | -$1.655M |
YoY Change | -85.1% | -103.84% | -17.42% |
Interest Expense | -$194.0K | -$144.0K | -$276.0K |
YoY Change | -220.5% | -184.21% | -42.26% |
% of Operating Profit | -218.18% | ||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | -$511.0K | -$78.00K | -$1.931M |
YoY Change | -41.26% | -95.1% | -22.2% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$511.0K | -$78.00K | -$1.931M |
YoY Change | -41.06% | -95.1% | -22.2% |
Net Earnings / Revenue | -20.11% | -2.27% | -189.87% |
Basic Earnings Per Share | -$0.09 | -$0.01 | |
Diluted Earnings Per Share | -$0.09 | -$0.01 | -$0.67 |
COMMON SHARES | |||
Basic Shares Outstanding | 6.016M shares | 3.354M shares | 2.716M shares |
Diluted Shares Outstanding | 6.015M shares | 4.258M shares |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 | 2023 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $2.241M | $2.412M | $817.0K |
YoY Change | 138.4% | -28.68% | -85.32% |
Cash & Equivalents | $2.241M | $2.412M | $620.0K |
Short-Term Investments | $0.00 | $0.00 | $197.0K |
Other Short-Term Assets | $781.0K | $1.281M | $1.905M |
YoY Change | -27.01% | 38.64% | 68.73% |
Inventory | $2.372M | $2.158M | $2.526M |
Prepaid Expenses | $198.0K | ||
Receivables | $1.828M | $690.0K | $664.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $7.222M | $6.541M | $5.912M |
YoY Change | 33.37% | -16.92% | -45.8% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $52.00K | $55.00K | $61.00K |
YoY Change | -21.21% | -21.43% | -23.75% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $1.476M | $1.761M | $5.250M |
YoY Change | -74.01% | -68.73% | 37.0% |
Total Long-Term Assets | $1.528M | $1.816M | $5.311M |
YoY Change | -73.39% | -68.15% | 35.76% |
TOTAL ASSETS | |||
Total Short-Term Assets | $7.222M | $6.541M | $5.912M |
Total Long-Term Assets | $1.528M | $1.816M | $5.311M |
Total Assets | $8.750M | $8.357M | $11.22M |
YoY Change | -21.58% | -38.43% | -24.27% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $893.0K | $1.421M | $1.769M |
YoY Change | -59.22% | -25.91% | -0.67% |
Accrued Expenses | $2.218M | $2.557M | $2.682M |
YoY Change | 6.63% | 11.08% | 125.38% |
Deferred Revenue | $277.0K | $206.0K | $389.0K |
YoY Change | |||
Short-Term Debt | $927.0K | $1.045M | $0.00 |
YoY Change | |||
Long-Term Debt Due | $460.0K | $1.335M | |
YoY Change | -62.39% | 141.41% | |
Total Short-Term Liabilities | $5.075M | $6.471M | $6.912M |
YoY Change | -23.47% | -3.65% | 11.45% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $150.0K | $263.0K | $3.154M |
YoY Change | -95.28% | -92.39% | -31.81% |
Other Long-Term Liabilities | $16.00K | $27.00K | $769.0K |
YoY Change | -36.0% | -15.63% | 5.78% |
Total Long-Term Liabilities | $614.0K | $749.0K | $3.923M |
YoY Change | -82.87% | -86.3% | -26.7% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $5.075M | $6.471M | $6.912M |
Total Long-Term Liabilities | $614.0K | $749.0K | $3.923M |
Total Liabilities | $5.689M | $7.220M | $10.84M |
YoY Change | -44.31% | -40.75% | -6.22% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$42.26M | -$41.75M | -$39.69M |
YoY Change | 11.93% | 13.18% | 18.82% |
Common Stock | $1.000K | $1.000K | $39.92M |
YoY Change | -100.0% | 0.0% | 3991600.0% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $2.833M | $936.0K | $388.0K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $8.750M | $8.357M | $11.22M |
YoY Change | -21.58% | -38.43% | -24.27% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 | 2023 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$511.0K | -$78.00K | -$1.931M |
YoY Change | -41.06% | -95.1% | -22.2% |
Depreciation, Depletion And Amortization | $3.000K | $4.000K | $7.000K |
YoY Change | -70.0% | -33.33% | -216.67% |
Cash From Operating Activities | -$2.438M | -$2.140M | -$1.387M |
YoY Change | 8.36% | 73.42% | -30.37% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $0.00 | -$1.000K |
YoY Change | -100.0% | -97.06% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $198.0K | $2.390M |
YoY Change | -100.0% | -80.42% | -160.26% |
Cash From Investing Activities | $0.00 | $198.0K | $2.391M |
YoY Change | -100.0% | -80.42% | -160.81% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 1.621M | 167.0K | 1.171M |
YoY Change | -953.16% | -94.47% | -257.82% |
NET CHANGE | |||
Cash From Operating Activities | -2.438M | -2.140M | -1.387M |
Cash From Investing Activities | 0.000 | 198.0K | 2.391M |
Cash From Financing Activities | 1.621M | 167.0K | 1.171M |
Net Change In Cash | -817.0K | -1.775M | 2.175M |
YoY Change | -51.66% | -163.42% | -132.63% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$2.438M | -$2.140M | -$1.387M |
Capital Expenditures | $0.00 | $0.00 | -$1.000K |
Free Cash Flow | -$2.438M | -$2.140M | -$1.386M |
YoY Change | 7.88% | 73.42% | -29.21% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2033747 | shares | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.51 | ||
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.68 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.72 | ||
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2333381 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4000994 | shares | |
CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
CY2024Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41375 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
ACTELIS NETWORKS, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
52-2160309 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
4039 Clipper Court | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Fremont | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
94538 | ||
dei |
City Area Code
CityAreaCode
|
(510) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
545-1045 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.0001 par value per share | ||
dei |
Trading Symbol
TradingSymbol
|
ASNS | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
6016326 | shares |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2412000 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
620000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
|
790000 | usd |
CY2024Q2 | us-gaap |
Assets Current
AssetsCurrent
|
6541000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
5912000 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
55000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
61000 | usd |
CY2024Q2 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
592000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
592000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
160000 | usd |
CY2023Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
3330000 | usd |
CY2024Q2 | asns |
Restricted Bank Deposits Noncurrent
RestrictedBankDepositsNoncurrent
|
89000 | usd |
CY2023Q4 | asns |
Restricted Bank Deposits Noncurrent
RestrictedBankDepositsNoncurrent
|
94000 | usd |
CY2024Q2 | asns |
Severance Pay Fund Noncurrent
SeverancePayFundNoncurrent
|
235000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
608000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
918000 | usd |
CY2023Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
78000 | usd |
CY2024Q2 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
1816000 | usd |
CY2023Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
5311000 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
8357000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
11223000 | usd |
CY2024Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
1045000 | usd |
CY2024Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
460000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
1335000 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
1421000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
1769000 | usd |
CY2024Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
206000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
389000 | usd |
CY2024Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
782000 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
737000 | usd |
CY2024Q2 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
1119000 | usd |
CY2023Q4 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
1062000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
443000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
498000 | usd |
CY2024Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
995000 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1122000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6912000 | usd |
CY2024Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
263000 | usd |
CY2024Q2 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
45000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
151000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
405000 | usd |
CY2024Q2 | asns |
Accrued Severance Noncurrent
AccruedSeveranceNoncurrent
|
263000 | usd |
CY2024Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
27000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
23000 | usd |
CY2024Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
749000 | usd |
CY2023Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
3923000 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
7220000 | usd |
CY2023Q4 | us-gaap |
Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
|
1565000 | usd |
CY2023Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
197000 | usd |
CY2024Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
168000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
168000 | usd |
CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
690000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
664000 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
2158000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
2526000 | usd |
CY2024Q2 | asns |
Allowance For Doubtful Debts Prepaid Expenses
AllowanceForDoubtfulDebtsPrepaidExpenses
|
181000 | usd |
CY2023Q4 | asns |
Allowance For Doubtful Debts Prepaid Expenses
AllowanceForDoubtfulDebtsPrepaidExpenses
|
144000 | usd |
CY2024Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
491000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
340000 | usd |
CY2024Q2 | us-gaap |
Assets Current
AssetsCurrent
|
6541000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
5912000 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
55000 | usd |
CY2024Q2 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
592000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
592000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
160000 | usd |
CY2023Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
3330000 | usd |
CY2024Q2 | asns |
Restricted Bank Deposits Noncurrent
RestrictedBankDepositsNoncurrent
|
89000 | usd |
CY2023Q4 | asns |
Restricted Bank Deposits Noncurrent
RestrictedBankDepositsNoncurrent
|
94000 | usd |
CY2024Q2 | asns |
Severance Pay Fund Noncurrent
SeverancePayFundNoncurrent
|
235000 | usd |
CY2023Q4 | asns |
Severance Pay Fund Noncurrent
SeverancePayFundNoncurrent
|
238000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
608000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
918000 | usd |
CY2024Q2 | us-gaap |
Long Term Investments
LongTermInvestments
|
77000 | usd |
CY2023Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
78000 | usd |
CY2024Q2 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
1816000 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
8357000 | usd |
CY2024Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
1045000 | usd |
CY2024Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
460000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
1335000 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
1421000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
1769000 | usd |
CY2024Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
206000 | usd |
CY2024Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
782000 | usd |
CY2024Q2 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
1119000 | usd |
CY2023Q4 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
1062000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
443000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
498000 | usd |
CY2024Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
995000 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1122000 | usd |
CY2024Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6471000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6912000 | usd |
CY2024Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
263000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
3154000 | usd |
CY2024Q2 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
45000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
71000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
151000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
405000 | usd |
CY2024Q2 | asns |
Accrued Severance Noncurrent
AccruedSeveranceNoncurrent
|
263000 | usd |
CY2023Q4 | asns |
Accrued Severance Noncurrent
AccruedSeveranceNoncurrent
|
270000 | usd |
CY2024Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
27000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
23000 | usd |
CY2024Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
749000 | usd |
CY2023Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
3923000 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
7220000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
10835000 | usd |
CY2024Q2 | asns |
Warrants To Placement Agent
WarrantsToPlacementAgent
|
201000 | usd |
CY2023Q4 | asns |
Warrants To Placement Agent
WarrantsToPlacementAgent
|
159000 | usd |
CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5017322 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5017322 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3007745 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3007745 | shares |
CY2024Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
42687000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
39916000 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-41752000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-39688000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
936000 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8357000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11223000 | usd |
us-gaap |
Revenues
Revenues
|
4157000 | usd | |
us-gaap |
Revenues
Revenues
|
3744000 | usd | |
CY2024Q2 | us-gaap |
Revenues
Revenues
|
3431000 | usd |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
1896000 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
2424000 | usd | |
CY2024Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1488000 | usd |
CY2023Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1264000 | usd |
us-gaap |
Gross Profit
GrossProfit
|
1320000 | usd | |
CY2024Q2 | us-gaap |
Gross Profit
GrossProfit
|
1943000 | usd |
CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
632000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1250000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1426000 | usd | |
CY2024Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
603000 | usd |
CY2023Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
669000 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1274000 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1641000 | usd | |
CY2024Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
647000 | usd |
CY2023Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
712000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1607000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1834000 | usd | |
CY2024Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
790000 | usd |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
969000 | usd |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
163000 | usd | |
CY2024Q2 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
163000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
3968000 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
4901000 | usd | |
CY2024Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
1877000 | usd |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2350000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1805000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3581000 | usd | |
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
66000 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1718000 | usd |
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
344000 | usd | |
CY2024Q2 | asns |
Warrants To Placement Agent
WarrantsToPlacementAgent
|
201000 | usd |
CY2023Q4 | asns |
Warrants To Placement Agent
WarrantsToPlacementAgent
|
159000 | usd |
CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5017322 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5017322 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
42687000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
39916000 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-41752000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-39688000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
936000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
229000 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8357000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11223000 | usd |
us-gaap |
Revenues
Revenues
|
4157000 | usd | |
us-gaap |
Revenues
Revenues
|
3744000 | usd | |
CY2024Q2 | us-gaap |
Revenues
Revenues
|
3431000 | usd |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
1896000 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
1994000 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
2424000 | usd | |
CY2024Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1488000 | usd |
CY2023Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1264000 | usd |
us-gaap |
Gross Profit
GrossProfit
|
2163000 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
1320000 | usd | |
CY2024Q2 | us-gaap |
Gross Profit
GrossProfit
|
1943000 | usd |
CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
632000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1250000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1426000 | usd | |
CY2024Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
603000 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1274000 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1641000 | usd | |
CY2024Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
647000 | usd |
CY2023Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
712000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1607000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1834000 | usd | |
CY2024Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
790000 | usd |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
163000 | usd | |
CY2024Q2 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
163000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
3968000 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
4901000 | usd | |
CY2024Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
1877000 | usd |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2350000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1805000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3581000 | usd | |
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
66000 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1718000 | usd |
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
351000 | usd | |
CY2024Q2 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
137000 | usd |
CY2023Q2 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
171000 | usd |
us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
85000 | usd | |
us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
444000 | usd | |
CY2024Q2 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
7000 | usd |
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
351000 | usd | |
CY2024Q2 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
137000 | usd |
CY2023Q2 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
171000 | usd |
us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
85000 | usd | |
us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
444000 | usd | |
CY2024Q2 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
7000 | usd |
CY2023Q2 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
296000 | usd |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2064000 | usd | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3488000 | usd | |
CY2024Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-78000 | usd |
CY2023Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1593000 | usd |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.51 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.72 | ||
CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.68 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4000994 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2033747 | shares | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4257674 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2333381 | shares |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3265000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
192000 | usd | |
us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
50000 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1356000 | usd | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
10000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3488000 | usd | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
229000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
179000 | usd | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
32000 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
2560000 | usd | |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
936000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1415000 | usd |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
97000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1593000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1285000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1668000 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
90000 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
2560000 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-78000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
936000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2064000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3488000 | usd | |
us-gaap |
Depreciation
Depreciation
|
8000 | usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-396000 | usd | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
223000 | usd | |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
25000 | usd | |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
97000 | usd | |
asns |
Exchange Rate Difference
ExchangeRateDifference
|
79000 | usd | |
asns |
Exchange Rate Difference
ExchangeRateDifference
|
226000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
179000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
192000 | usd | |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-4000 | usd | |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
64000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1275000 | usd | |
us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-1000 | usd | |
us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-24000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-342000 | usd | |
CY2023Q2 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
296000 | usd |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2064000 | usd | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3488000 | usd | |
CY2024Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-78000 | usd |
CY2023Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1593000 | usd |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.51 | ||
CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2033747 | shares | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4257674 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2333381 | shares |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3265000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
192000 | usd | |
us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
50000 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1356000 | usd | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
10000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3488000 | usd | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1285000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
229000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
179000 | usd | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
32000 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
2560000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2064000 | usd | |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
936000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1415000 | usd |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
97000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1356000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
10000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1593000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1285000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1668000 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
90000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
32000 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
2560000 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-78000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
936000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3488000 | usd | |
us-gaap |
Depreciation
Depreciation
|
8000 | usd | |
us-gaap |
Depreciation
Depreciation
|
13000 | usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-396000 | usd | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
223000 | usd | |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
25000 | usd | |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
97000 | usd | |
asns |
Exchange Rate Difference
ExchangeRateDifference
|
79000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
192000 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
-41000 | usd | |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-4000 | usd | |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
64000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
26000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1275000 | usd | |
us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-1000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
726000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
150000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-208000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-347000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
137000 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-209000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
726000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
150000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-208000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-347000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
137000 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-209000 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-155000 | usd | |
us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
14000 | usd | |
us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-36000 | usd | |
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-17000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2343000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2939000 | usd | |
asns |
Proceedsfrom Short Term Deposits
ProceedsfromShortTermDeposits
|
198000 | usd | |
asns |
Proceedsfrom Short Term Deposits
ProceedsfromShortTermDeposits
|
810000 | usd | |
asns |
Paymentto Short Term Restricted Bank Deposits
PaymenttoShortTermRestrictedBankDeposits
|
125000 | usd | |
asns |
Payments For Proceeds From Long Term Deposit
PaymentsForProceedsFromLongTermDeposit
|
5000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
197000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
677000 | usd | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
32000 | usd | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
50000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
3500000 | usd | |
asns |
Proceeds From Warrant Inducement Agreement
ProceedsFromWarrantInducementAgreement
|
2999000 | usd | |
asns |
Underwriting Discounts And Commissions And Other Offering Costs
UnderwritingDiscountsAndCommissionsAndOtherOfferingCosts
|
397000 | usd | |
asns |
Underwriting Discounts And Commissions And Other Offering Costs
UnderwritingDiscountsAndCommissionsAndOtherOfferingCosts
|
291000 | usd | |
us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
1045000 | usd | |
us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
-3483000 | usd | |
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
193000 | usd | |
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
389000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2780000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-10000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-10000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2153000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
508000 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5515000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4279000 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3362000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4787000 | usd |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2412000 | usd |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2573000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
|
160000 | usd |
CY2023Q2 | us-gaap |
Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
|
2214000 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3362000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4787000 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
326000 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
351000 | usd | |
asns |
Issuance Costs Of Common Stock Prefunded Warrants And Warrants
IssuanceCostsOfCommonStockPrefundedWarrantsAndWarrants
|
104000 | usd | |
asns |
Issuance Costs Of The Warrant Inducement Agreement
IssuanceCostsOfTheWarrantInducementAgreement
|
1493000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2064000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2343000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2939000 | usd | |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-41752000 | usd |
CY2024Q2 | us-gaap |
Cash
Cash
|
3202000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash And Investments
RestrictedCashAndInvestments
|
249000 | usd |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-155000 | usd | |
us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
14000 | usd | |
us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-36000 | usd | |
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-17000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2343000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2939000 | usd | |
asns |
Proceedsfrom Short Term Deposits
ProceedsfromShortTermDeposits
|
198000 | usd | |
asns |
Proceedsfrom Short Term Deposits
ProceedsfromShortTermDeposits
|
810000 | usd | |
asns |
Paymentto Short Term Restricted Bank Deposits
PaymenttoShortTermRestrictedBankDeposits
|
125000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
197000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
677000 | usd | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
32000 | usd | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
10000 | usd | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
50000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
3500000 | usd | |
asns |
Proceeds From Warrant Inducement Agreement
ProceedsFromWarrantInducementAgreement
|
2999000 | usd | |
asns |
Underwriting Discounts And Commissions And Other Offering Costs
UnderwritingDiscountsAndCommissionsAndOtherOfferingCosts
|
397000 | usd | |
us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
1045000 | usd | |
us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
-3483000 | usd | |
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
193000 | usd | |
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
389000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2780000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-10000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-10000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2153000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
508000 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5515000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4279000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4787000 | usd |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2412000 | usd |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2573000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
|
790000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
|
160000 | usd |
CY2023Q2 | us-gaap |
Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
|
2214000 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3362000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4787000 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
326000 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
351000 | usd | |
asns |
Issuance Costs Of Common Stock Prefunded Warrants And Warrants
IssuanceCostsOfCommonStockPrefundedWarrantsAndWarrants
|
104000 | usd | |
asns |
Issuance Costs Of The Warrant Inducement Agreement
IssuanceCostsOfTheWarrantInducementAgreement
|
1493000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2064000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2939000 | usd | |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-41752000 | usd |
CY2024Q2 | us-gaap |
Cash
Cash
|
3202000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash And Investments
RestrictedCashAndInvestments
|
249000 | usd |
us-gaap |
Other Income
OtherIncome
|
163 | usd | |
us-gaap |
Other Income
OtherIncome
|
163 | usd | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Use of estimates in preparation of financial statements</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, fair values of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><b>d.</b></td><td style="text-align: justify"><b>Concentration of risk</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and cash equivalents, trade receivables and other current assets. Cash and cash equivalents and restricted cash and cash equivalents are placed with banks and financial institutions in the United States and Israel.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, present minimal credit risk with respect to those investments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">The Company’s trade receivables are derived primarily from telecommunication operators, the Company’s reseller customers and enterprises located mainly in the United States, Europe, and Asia.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Credit risk with respect to trade receivables exists to the full extent of the amounts presented in the consolidated financial statements. Management makes judgments as to its ability to collect outstanding accounts receivable and provides allowances for the applicable portion of accounts receivable when collection becomes doubtful.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Management provides allowances based upon a specific review of all significant outstanding invoices, analysis of its historical collection experience, and current economic trends. If the historical data used to calculate the allowance for credit losses does not reflect the Company’s future ability to collect outstanding accounts receivable, additional provisions for credit losses may be needed, and the future results of operations could be materially affected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">The Company has customers balances representing 10% or more of Trade receivables as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Customer A represented </span><span style="font-size: 10pt">15</span><span style="font-family: Times New Roman, Times, Serif">% and 30% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Customer B represented </span><span style="font-size: 10pt">14</span><span style="font-family: Times New Roman, Times, Serif">% and 11% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">3)</span></td><td style="text-align: justify">Customer C represented 0% and 11% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">4)</span></td><td style="text-align: justify">Customer D represented 11% and 0% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 70.9pt"></td><td style="width: 18pt"><span style="font-size: 10pt">5)</span></td><td style="text-align: justify">Customer E represented 10% and 0% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">The Company does not see any credit risk regarding the major trade receivable balance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Use of estimates in preparation of financial statements</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, fair values of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><b>d.</b></td><td style="text-align: justify"><b>Concentration of risk</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and cash equivalents, trade receivables and other current assets. Cash and cash equivalents and restricted cash and cash equivalents are placed with banks and financial institutions in the United States and Israel.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, present minimal credit risk with respect to those investments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">The Company’s trade receivables are derived primarily from telecommunication operators, the Company’s reseller customers and enterprises located mainly in the United States, Europe, and Asia.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Credit risk with respect to trade receivables exists to the full extent of the amounts presented in the consolidated financial statements. Management makes judgments as to its ability to collect outstanding accounts receivable and provides allowances for the applicable portion of accounts receivable when collection becomes doubtful.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">Management provides allowances based upon a specific review of all significant outstanding invoices, analysis of its historical collection experience, and current economic trends. If the historical data used to calculate the allowance for credit losses does not reflect the Company’s future ability to collect outstanding accounts receivable, additional provisions for credit losses may be needed, and the future results of operations could be materially affected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">The Company has customers balances representing 10% or more of Trade receivables as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Customer A represented </span><span style="font-size: 10pt">15</span><span style="font-family: Times New Roman, Times, Serif">% and 30% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Customer B represented </span><span style="font-size: 10pt">14</span><span style="font-family: Times New Roman, Times, Serif">% and 11% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">3)</span></td><td style="text-align: justify">Customer C represented 0% and 11% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">4)</span></td><td style="text-align: justify">Customer D represented 11% and 0% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 70.9pt"></td><td style="width: 18pt"><span style="font-size: 10pt">5)</span></td><td style="text-align: justify">Customer E represented 10% and 0% of the Company Trade receivables balance as of June 30, 2024, and December 31, 2023, respectively.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">The Company does not see any credit risk regarding the major trade receivable balance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | ||
CY2024Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
1132000 | usd |
CY2023Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
757000 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1769000 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
2158000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
2526000 | usd |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
25000 | usd | |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
97000 | usd | |
CY2024Q2 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
25 | usd |
CY2023Q2 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
90 | usd |
CY2024Q2 | us-gaap |
Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
|
2000 | usd |
CY2020Q4 | us-gaap |
Loans Payable
LoansPayable
|
20000000 | ils |
CY2020Q4 | us-gaap |
Loans Payable
LoansPayable
|
6000000 | usd |
CY2020Q4 | us-gaap |
Financing Receivable Loan In Process
FinancingReceivableLoanInProcess
|
3000000 | usd |
CY2021Q1 | us-gaap |
Financing Receivable Loan In Process
FinancingReceivableLoanInProcess
|
2000000 | usd |
CY2024Q2 | us-gaap |
Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
|
0.096 | pure |
CY2021Q4 | us-gaap |
Investment Company Increase From Payment By Affiliate And Gain Loss From Investment In Violation
InvestmentCompanyIncreaseFromPaymentByAffiliateAndGainLossFromInvestmentInViolation
|
1000000 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
|
0.096 | pure |
us-gaap |
Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
|
1800000 | usd | |
CY2022Q4 | us-gaap |
Carrying Value Of Securities Sold Under Repurchase Agreements And Deposits Received For Securities Loaned
CarryingValueOfSecuritiesSoldUnderRepurchaseAgreementsAndDepositsReceivedForSecuritiesLoaned
|
2000000 | usd |
CY2023Q4 | us-gaap |
Long Term Notes And Loans
LongTermNotesAndLoans
|
2000000 | usd |
CY2024Q2 | us-gaap |
Repayments Of Bank Debt
RepaymentsOfBankDebt
|
10900000 | ils |
CY2024Q2 | us-gaap |
Repayments Of Bank Debt
RepaymentsOfBankDebt
|
2933000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
|
0.096 | pure |
CY2024Q1 | us-gaap |
Stock Issued1
StockIssued1
|
150000 | usd |
us-gaap |
Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
|
1160000 | ils | |
us-gaap |
Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
|
308000 | usd | |
CY2024Q1 | us-gaap |
Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
|
0.015 | pure |
CY2024Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
1045000 | usd |
CY2023Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
757000 | usd |
CY2024Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1026000 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1769000 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
2158000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
2526000 | usd |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
25000 | usd | |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
97000 | usd | |
CY2024Q2 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
25 | usd |
CY2023Q2 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
90 | usd |
CY2024Q2 | us-gaap |
Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
|
2000 | usd |
CY2020Q4 | us-gaap |
Loans Payable
LoansPayable
|
20000000 | ils |
CY2020Q4 | us-gaap |
Loans Payable
LoansPayable
|
6000000 | usd |
CY2020Q4 | us-gaap |
Financing Receivable Loan In Process
FinancingReceivableLoanInProcess
|
3000000 | usd |
CY2021Q1 | us-gaap |
Financing Receivable Loan In Process
FinancingReceivableLoanInProcess
|
2000000 | usd |
CY2024Q2 | us-gaap |
Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
|
0.096 | pure |
CY2021Q4 | us-gaap |
Investment Company Increase From Payment By Affiliate And Gain Loss From Investment In Violation
InvestmentCompanyIncreaseFromPaymentByAffiliateAndGainLossFromInvestmentInViolation
|
1000000 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
|
0.096 | pure |
us-gaap |
Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
|
1800000 | usd | |
CY2022Q4 | us-gaap |
Carrying Value Of Securities Sold Under Repurchase Agreements And Deposits Received For Securities Loaned
CarryingValueOfSecuritiesSoldUnderRepurchaseAgreementsAndDepositsReceivedForSecuritiesLoaned
|
2000000 | usd |
CY2023Q4 | us-gaap |
Long Term Notes And Loans
LongTermNotesAndLoans
|
2000000 | usd |
CY2024Q1 | us-gaap |
Repayments Of Bank Debt
RepaymentsOfBankDebt
|
2000000 | ils |
CY2024Q1 | us-gaap |
Repayments Of Bank Debt
RepaymentsOfBankDebt
|
550000 | usd |
CY2024Q2 | us-gaap |
Repayments Of Bank Debt
RepaymentsOfBankDebt
|
10900000 | ils |
CY2024Q2 | us-gaap |
Repayments Of Bank Debt
RepaymentsOfBankDebt
|
2933000 | usd |
CY2024Q1 | us-gaap |
Stock Issued1
StockIssued1
|
150000 | usd |
us-gaap |
Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
|
308000 | usd | |
CY2024Q1 | us-gaap |
Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
|
0.015 | pure |
us-gaap |
Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
|
0.30 | pure | |
CY2024Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
1045000 | usd |
asns |
Royalties Paid Percentage
RoyaltiesPaidPercentage
|
1 | pure | |
CY2024Q2 | us-gaap |
Billed Contract Receivables
BilledContractReceivables
|
14300000 | usd |
CY2024Q2 | us-gaap |
Interest Receivable
InterestReceivable
|
15825000 | usd |
asns |
Repaid Amount
RepaidAmount
|
10275000 | usd | |
us-gaap |
Payments For Royalties
PaymentsForRoyalties
|
1119000 | usd | |
CY2023 | us-gaap |
Payments For Royalties
PaymentsForRoyalties
|
1062000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
190000 | shares |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | asns |
Prefunded Warrants To Purchase Common Stock
PrefundedWarrantsToPurchaseCommonStock
|
754670 | shares |
CY2023Q2 | asns |
Prefunded Warrants
PrefundedWarrants
|
754670 | shares |
CY2023Q2 | us-gaap |
Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
|
0.0001 | |
CY2023Q3 | asns |
Exercise Of Prefunded Warrant
ExerciseOfPrefundedWarrant
|
754670 | shares |
CY2023Q3 | asns |
Exercise Of Prefunded Warrant
ExerciseOfPrefundedWarrant
|
754670 | shares |
CY2023Q3 | asns |
Exercise Price Of Prefunded Warrant
ExercisePriceOfPrefundedWarrant
|
0.0755 | |
CY2023Q3 | asns |
Exercise Price Of Prefunded Warrant
ExercisePriceOfPrefundedWarrant
|
0.0755 | |
CY2023Q2 | asns |
Payments To Underwriter
PaymentsToUnderwriter
|
291000 | usd |
CY2023Q2 | asns |
Warrant Exercise Price Percentage
WarrantExercisePricePercentage
|
1.25 | pure |
CY2023Q4 | us-gaap |
Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
|
1500000 | usd |
CY2023Q4 | asns |
Prefunded Warrants To Purchase Common Stock
PrefundedWarrantsToPurchaseCommonStock
|
970187 | shares |
CY2023Q4 | asns |
Prefunded Warrants
PrefundedWarrants
|
970187 | shares |
CY2023Q4 | asns |
Exercise Price Of Prefunded Warrant
ExercisePriceOfPrefundedWarrant
|
0.0001 | |
asns |
Exercise Of Prefunded Warrant
ExerciseOfPrefundedWarrant
|
970187 | shares | |
asns |
Exercise Price Of Prefunded Warrant
ExercisePriceOfPrefundedWarrant
|
0.097 | ||
CY2023Q4 | asns |
Payments To Underwriter
PaymentsToUnderwriter
|
129000 | usd |
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
88983 | shares |
CY2023Q4 | asns |
Offering Share Price
OfferingSharePrice
|
1.475 | |
us-gaap |
Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
|
a 1:1 exchange ratio. As further consideration, the Holder agrees to pay $0.125 cents per newly issued warrant outlined above for a total of $249. | ||
asns |
Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisables
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisables
|
P5Y6M | ||
asns |
Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable Remaining
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisableRemaining
|
P2Y | ||
asns |
Existing Warrants Reduced Exercise Price
ExistingWarrantsReducedExercisePrice
|
-3437.5000 | usd | |
CY2024Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
1890 | usd |
asns |
Royalties Paid Percentage
RoyaltiesPaidPercentage
|
1 | pure | |
CY2024Q2 | us-gaap |
Billed Contract Receivables
BilledContractReceivables
|
14300000 | usd |
CY2024Q2 | us-gaap |
Interest Receivable
InterestReceivable
|
15825000 | usd |
asns |
Repaid Amount
RepaidAmount
|
10275000 | usd | |
us-gaap |
Payments For Royalties
PaymentsForRoyalties
|
1119000 | usd | |
CY2023 | us-gaap |
Payments For Royalties
PaymentsForRoyalties
|
1062000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
190000 | shares |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | asns |
Prefunded Warrants To Purchase Common Stock
PrefundedWarrantsToPurchaseCommonStock
|
754670 | shares |
CY2023Q2 | asns |
Prefunded Warrants
PrefundedWarrants
|
754670 | shares |
CY2023Q2 | us-gaap |
Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
|
0.0001 | |
CY2023Q3 | asns |
Exercise Of Prefunded Warrant
ExerciseOfPrefundedWarrant
|
754670 | shares |
CY2023Q3 | asns |
Exercise Of Prefunded Warrant
ExerciseOfPrefundedWarrant
|
754670 | shares |
CY2023Q3 | asns |
Exercise Price Of Prefunded Warrant
ExercisePriceOfPrefundedWarrant
|
0.0755 | |
CY2023Q3 | asns |
Exercise Price Of Prefunded Warrant
ExercisePriceOfPrefundedWarrant
|
0.0755 | |
CY2023Q2 | asns |
Payments To Underwriter
PaymentsToUnderwriter
|
291000 | usd |
CY2023Q2 | asns |
Warrant Exercise Price Percentage
WarrantExercisePricePercentage
|
1.25 | pure |
CY2023Q4 | us-gaap |
Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
|
1500000 | usd |
CY2023Q4 | asns |
Prefunded Warrants To Purchase Common Stock
PrefundedWarrantsToPurchaseCommonStock
|
970187 | shares |
CY2023Q4 | asns |
Prefunded Warrants
PrefundedWarrants
|
970187 | shares |
CY2023Q4 | asns |
Exercise Price Of Prefunded Warrant
ExercisePriceOfPrefundedWarrant
|
0.0001 | |
asns |
Exercise Of Prefunded Warrant
ExerciseOfPrefundedWarrant
|
970187 | shares | |
asns |
Exercise Price Of Prefunded Warrant
ExercisePriceOfPrefundedWarrant
|
0.097 | ||
CY2023Q4 | asns |
Payments To Underwriter
PaymentsToUnderwriter
|
129000 | usd |
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
88983 | shares |
CY2023Q4 | asns |
Offering Share Price
OfferingSharePrice
|
1.475 | |
CY2023Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y6M | |
CY2023Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
230000 | usd |
us-gaap |
Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
|
a 1:1 exchange ratio. As further consideration, the Holder agrees to pay $0.125 cents per newly issued warrant outlined above for a total of $249. | ||
asns |
Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisables
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisables
|
P5Y6M | ||
asns |
Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable Remaining
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisableRemaining
|
P2Y | ||
asns |
Existing Warrants Reduced Exercise Price
ExistingWarrantsReducedExercisePrice
|
-3437.5000 | usd | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
87764 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.63 | |
CY2023Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y1M9D | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
21225 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
3.37 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
1362 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
4.73 | ||
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
65102 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.39 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y7M6D | ||
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
58818 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.11 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y2M12D | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
65102 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
93708 | shares | |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
|
4.39 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
|
4.81 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2064000 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
3159451000 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
1800665000 | usd | |
CY2024Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
3998957000 | usd |
asns |
Pre Funded Warrants To Purchase Common Shares
PreFundedWarrantsToPurchaseCommonShares
|
841543 | shares | |
asns |
Pre Funded Warrants To Purchase Common Shares
PreFundedWarrantsToPurchaseCommonShares
|
238979 | shares | |
CY2024Q2 | asns |
Pre Funded Warrants To Purchase Common Shares
PreFundedWarrantsToPurchaseCommonShares
|
258717 | shares |
asns |
Repurchase Of Common Stock
RepurchaseOfCommonStock
|
5896000 | usd | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4000994 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2033747 | shares | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.72 | ||
CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.63 | |
CY2023Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y1M9D | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
21225 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
3.37 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
4.73 | ||
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.39 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y7M6D | ||
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
58818 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.11 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y2M12D | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
65102 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
93708 | shares | |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
|
4.39 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
|
4.81 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2064000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3488000 | usd | |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-78000 | usd |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
1800665000 | usd | |
asns |
Pre Funded Warrants To Purchase Common Shares
PreFundedWarrantsToPurchaseCommonShares
|
841543 | shares | |
asns |
Pre Funded Warrants To Purchase Common Shares
PreFundedWarrantsToPurchaseCommonShares
|
238979 | shares | |
asns |
Repurchase Of Common Stock
RepurchaseOfCommonStock
|
5896000 | usd | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4000994 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2033747 | shares | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4257674 | shares |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.51 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.72 | ||
CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | pure | |
asns |
Revenue
Revenue
|
4158000 | usd | |
asns |
Revenue
Revenue
|
3744000 | usd | |
CY2024Q2 | asns |
Revenue
Revenue
|
3431000 | usd |
CY2023Q2 | asns |
Revenue
Revenue
|
1896000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
460000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
648000 | usd |
us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
364000 | usd | |
CY2023 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
544000 | usd |
asns |
Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
|
155000 | usd | |
CY2023 | asns |
Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
|
356000 | usd |
CY2024Q2 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
251000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
460000 | usd |
CY2024Q2 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
251000 | usd |
CY2024Q2 | us-gaap |
Excess Stock Shares Issued
ExcessStockSharesIssued
|
69977 | shares |
asns |
Existing Warrants Being Exercised
ExistingWarrantsBeingExercised
|
0.07 | pure | |
us-gaap |
Warrant Exercise Price Increase
WarrantExercisePriceIncrease
|
2.5 | ||
asns |
Exercise Price Percentage
ExercisePricePercentage
|
1.25 | pure | |
CY2024Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q2 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q2 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | pure | |
asns |
Revenue
Revenue
|
4158000 | usd | |
asns |
Revenue
Revenue
|
3744000 | usd | |
CY2024Q2 | asns |
Revenue
Revenue
|
3431000 | usd |
CY2023Q2 | asns |
Revenue
Revenue
|
1896000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
460000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
648000 | usd |
us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
364000 | usd | |
CY2023 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
544000 | usd |
asns |
Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
|
155000 | usd | |
CY2023 | asns |
Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
|
356000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
460000 | usd |
CY2024Q2 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
251000 | usd |
CY2024Q2 | us-gaap |
Excess Stock Shares Issued
ExcessStockSharesIssued
|
69977 | shares |
asns |
Existing Warrants Being Exercised
ExistingWarrantsBeingExercised
|
0.07 | pure | |
us-gaap |
Warrant Exercise Price Increase
WarrantExercisePriceIncrease
|
2.5 | ||
asns |
Exercise Price Percentage
ExercisePricePercentage
|
1.25 | pure | |
CY2024Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q2 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q2 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
usd | ||
CY2023Q2 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
usd | |
us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
usd | ||
CY2024Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
usd | |
CY2024Q2 | asns |
Exercise Of Pre Funded Warrants Into Common Stock.
ExerciseOfPreFundedWarrantsIntoCommonStock.
|
usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | ||
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
usd | ||
CY2024Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
usd | ||
CY2023Q2 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
usd | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4257674 | shares |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
usd | |
CY2024Q2 | asns |
Exercise Of Pre Funded Warrants Into Common Stock.
ExerciseOfPreFundedWarrantsIntoCommonStock.
|
usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | ||
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
usd | ||
us-gaap |
Interest Expense
InterestExpense
|
usd | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
usd | ||
asns |
Paymentto Short Term Restricted Bank Deposits
PaymenttoShortTermRestrictedBankDeposits
|
usd | ||
asns |
Payments For Proceeds From Long Term Deposit
PaymentsForProceedsFromLongTermDeposit
|
usd | ||
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
usd | ||
asns |
Proceeds From Warrant Inducement Agreement
ProceedsFromWarrantInducementAgreement
|
usd | ||
us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
usd | ||
us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
usd | ||
CY2023Q2 | us-gaap |
Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
|
usd | |
asns |
Issuance Costs Of The Warrant Inducement Agreement
IssuanceCostsOfTheWarrantInducementAgreement
|
usd | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
|||
asns |
Repurchase Of Common Stock
RepurchaseOfCommonStock
|
usd | ||
CY2024Q2 | asns |
Repurchase Of Common Stock
RepurchaseOfCommonStock
|
usd | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2033747 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4000994 | shares | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4257674 | shares |
CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.51 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.72 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001141284 | ||
us-gaap |
Interest Expense
InterestExpense
|
usd | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
usd | ||
asns |
Paymentto Short Term Restricted Bank Deposits
PaymenttoShortTermRestrictedBankDeposits
|
usd | ||
asns |
Payments For Proceeds From Long Term Deposit
PaymentsForProceedsFromLongTermDeposit
|
usd | ||
asns |
Proceeds From Warrant Inducement Agreement
ProceedsFromWarrantInducementAgreement
|
usd | ||
us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
usd | ||
us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
usd | ||
CY2023Q2 | us-gaap |
Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
|
usd | |
asns |
Issuance Costs Of Common Stock Prefunded Warrants And Warrants
IssuanceCostsOfCommonStockPrefundedWarrantsAndWarrants
|
usd | ||
asns |
Issuance Costs Of The Warrant Inducement Agreement
IssuanceCostsOfTheWarrantInducementAgreement
|
usd | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3488000 | usd | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
|||
CY2024Q2 | asns |
Repurchase Of Common Stock
RepurchaseOfCommonStock
|
usd | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2033747 | shares | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4257674 | shares |
CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001141284 |